Related Experiment Videos
The complement system in uremia
Insights
Chronic kidney disease patients on dialysis or conservative treatment showed lower levels of complement components C3 and C3 proactivator compared to healthy individuals. Other measured complement factors remained unchanged in these kidney disease patients.
Area of Science:
- Immunology
- Nephrology
Background:
- The complement system plays a crucial role in innate immunity.
- Alterations in complement component levels may be associated with chronic kidney disease (CKD).
Purpose of the Study:
- To investigate complement component levels in patients with chronic uremia undergoing different treatment modalities.
- To compare complement profiles between CKD patients and healthy controls.
Main Methods:
- Quantification of plasma C1q, C1 esterase inactivator, C4, C3, and C3 proactivator.
- Study included 20 maintenance hemodialysis patients, 10 conservatively treated CKD patients, and 20 healthy volunteers.
Main Results:
- No significant differences in C1q, C1 esterase inactivator, and C4 levels were observed between patient groups and controls.
- Significantly lower levels of C3 and C3 proactivator were found in both hemodialysis and conservatively treated CKD patients compared to healthy volunteers.
Conclusions:
- Chronic uremia is associated with reduced levels of C3 and C3 proactivator, irrespective of treatment modality.
- These findings suggest a potential dysregulation of the complement system in CKD affecting specific components.
Abstract:
Plasma C1q, C1 esterase inactivator, C4, C3 and C3 proactivator were measured in 20 chronic uremic patients on maintenance hemodialysis, in 10 conservatively treated chronic uremic patients and in 20 healthy volunteers. There was no statistical significant difference between the patient groups in any of the measured complement components. The C1q, C1 esterase inactivator and C4 concentration were found to be the same in the patient and the control groups. The C3 and C3 proactivator levels were equally and significantly lower in both patient groups compared with the healthy volunteers.